Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur B Pardee

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Gene|November 26, 2003
Beginnings of feedback inhibition, allostery, and multi-protein complexesArthur B Pardee, G Prem-Veer Reddy
Journal of Cellular Physiology|November 7, 2008
Metastasis and AKT activationShijie Sheng, Meng Qiao, Arthur B Pardee
Cancer Research|June 5, 2007
Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activationMeng Qiao, J Dirk Iglehart, Arthur B Pardee
Nature Protocols|April 5, 2007
A protocol for differential display of mRNA expression using either fluorescent or radioactive labelingPeng Liang, Jonathan D Meade, Arthur B Pardee
Current Cancer Drug Targets|August 22, 2002
Cancer therapy with beta-lapachoneArthur B Pardee, You Zhi Li, Chiang J Li
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Regulation in S phase by E2FArthur B Pardee, Chiang J Li, G Prem Veer Reddy
Methods in Molecular Medicine|November 1, 2002
Sensitive assays for detection of lung cancer. Molecular markers in blood samplesMarcia V Fournier, Katherine J Martin, Edgard Graner, et al.
Cancer Research|September 6, 2005
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevationAjin Wang, Chiang J Li, Prem V Reddy, et al.
Cancer Research|July 1, 2010
A need for basic research on fluid-based early detection biomarkersKatherine J Martin, Marcia V Fournier, G Prem Veer Reddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancerYouzhi Li, Xiangao Sun, J Thomas LaMont, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Gene|November 26, 2003
Beginnings of feedback inhibition, allostery, and multi-protein complexesArthur B Pardee, G Prem-Veer Reddy
Journal of Cellular Physiology|November 7, 2008
Metastasis and AKT activationShijie Sheng, Meng Qiao, Arthur B Pardee
Cancer Research|June 5, 2007
Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activationMeng Qiao, J Dirk Iglehart, Arthur B Pardee
Nature Protocols|April 5, 2007
A protocol for differential display of mRNA expression using either fluorescent or radioactive labelingPeng Liang, Jonathan D Meade, Arthur B Pardee
Current Cancer Drug Targets|August 22, 2002
Cancer therapy with beta-lapachoneArthur B Pardee, You Zhi Li, Chiang J Li
Cell Cycle (Georgetown, Tex.)|October 7, 2004
Regulation in S phase by E2FArthur B Pardee, Chiang J Li, G Prem Veer Reddy
Methods in Molecular Medicine|November 1, 2002
Sensitive assays for detection of lung cancer. Molecular markers in blood samplesMarcia V Fournier, Katherine J Martin, Edgard Graner, et al.
Cancer Research|September 6, 2005
Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevationAjin Wang, Chiang J Li, Prem V Reddy, et al.
Cancer Research|July 1, 2010
A need for basic research on fluid-based early detection biomarkersKatherine J Martin, Marcia V Fournier, G Prem Veer Reddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancerYouzhi Li, Xiangao Sun, J Thomas LaMont, et al.
Pageof 4